ATAD2 and cancer: The important function of ATAD2 in cancer attracts deep insight into the structure of ATAD2, and surprisingly, the bromodomain of ATAD2 has been validated to be a pharmacologically tractable target and a series of inhibitors are disclosing [19–21].